CVS Health (NYSE:CVS) Upgraded at Edward Jones

CVS Health (NYSE:CVS - Get Free Report) was upgraded by analysts at Edward Jones from a "hold" rating to a "buy" rating in a report released on Thursday, MarketBeat Ratings reports.

Several other brokerages also recently weighed in on CVS. TD Cowen upped their price target on CVS Health from $73.00 to $80.00 and gave the stock a "buy" rating in a report on Monday, November 25th. UBS Group raised their target price on shares of CVS Health from $60.00 to $62.00 and gave the company a "neutral" rating in a report on Thursday, November 7th. Deutsche Bank Aktiengesellschaft upgraded shares of CVS Health from a "hold" rating to a "buy" rating and set a $66.00 price target for the company in a report on Tuesday, December 3rd. Evercore ISI raised their price objective on shares of CVS Health from $60.00 to $65.00 and gave the company an "outperform" rating in a report on Monday. Finally, Mizuho lowered their target price on shares of CVS Health from $73.00 to $66.00 and set an "outperform" rating for the company in a research note on Thursday, October 24th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and fourteen have assigned a buy rating to the company's stock. According to data from MarketBeat.com, CVS Health has an average rating of "Moderate Buy" and a consensus price target of $68.12.

CVS Health Trading Down 0.5 %

Shares of NYSE:CVS traded down $0.29 during mid-day trading on Thursday, reaching $56.53. 10,819,890 shares of the company were exchanged, compared to its average volume of 13,384,287. CVS Health has a 1 year low of $43.56 and a 1 year high of $80.75. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. The firm's 50-day simple moving average is $51.27 and its 200 day simple moving average is $56.17. The firm has a market cap of $71.13 billion, a price-to-earnings ratio of 14.35, a P/E/G ratio of 0.62 and a beta of 0.59.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, topping the consensus estimate of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The business had revenue of $95.43 billion during the quarter, compared to analyst estimates of $92.72 billion. During the same period last year, the business posted $2.21 earnings per share. The company's quarterly revenue was up 6.3% on a year-over-year basis. Equities research analysts forecast that CVS Health will post 5.18 EPS for the current year.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the business. MidAtlantic Capital Management Inc. purchased a new position in CVS Health in the 3rd quarter valued at $25,000. Livelsberger Financial Advisory acquired a new position in shares of CVS Health during the third quarter worth about $31,000. Legacy Investment Solutions LLC purchased a new position in CVS Health during the third quarter worth about $31,000. Reston Wealth Management LLC purchased a new stake in CVS Health in the 3rd quarter valued at approximately $32,000. Finally, Kathleen S. Wright Associates Inc. acquired a new position in CVS Health during the 3rd quarter worth approximately $33,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.